SkinSight™ AI by ModuleMD: Smarter Skin Analysis, Faster Clinical Decisions

10.12.25 18:00 Uhr

GRAND BLANC, Mich., Dec. 10, 2025 /PRNewswire/ -- ModuleMD, ranked as one of America's fastest-growing companies on the Inc. 5000 and top-rated EHR vendor on G2, announces SkinSight™ AI, a solution that brings automation, accuracy, and consistency to one of the most manual and variable workflows in allergy care: skin test measurement and documentation.

Module MD Logo

For years, allergy practices have been expected to deliver better documentation, clearer outcomes, and stronger patient communication while reimbursement remains unchanged.

SkinSight™ AI introduces a new era of standardization that meets these growing operational demands without adding work, steps, or hardware.

Why SkinSight™ AI Matters Today

Allergy skin testing remains highly subjective, often relying on staff experience, manual measurement, and individual interpretation. SkinSight™ AI removes these inconsistencies and replaces them with an objective, data-driven process designed for accuracy, efficiency, and trust.

SkinSight™ AI delivers:

  • More objective and consistent measurements
    Standardizes grading across staff, days, and clinic locations, reducing human variability and ensuring every reaction is evaluated the same way.

  • Increased accuracy in identifying wheal and flare boundaries
    Precisely detects subtle and irregular reactions that are difficult for the human eye to measure.

  • Saves time during the patient visit
    Automates measurement and grading in seconds, freeing up several minutes per test without changing workflow.

  • Automatically documents results to the patient record
    Structured, time-stamped measurements and images flow directly into the EHR, eliminating manual entry and reducing errors.

  • Supports research and outcomes analysis
    Aggregates usable data for trend studies, protocol refinement, and practice-driven clinical research.

  • Builds patient trust in test results
    Transparent measurements and visuals make results easier for patients to understand and increase confidence in the care they receive.

  • Enables review of test results later
    Improves follow-up conversations by allowing clinicians to revisit past results with clarity and precision.

  • Allows visual timeline comparisons
    Tracks reaction progression over time to support treatment decisions, therapy adjustments, and patient education.
  • How SkinSight™ AI Works

    After the skin test panel is placed, staff simply captures an image using the device they already have. SkinSight™ AI instantly:

    • Detects positive reactions
    • Measures wheal and flare size
    • Identifies clinically meaningful responses
    • Documents structured results directly into the patient chart

    No new steps. No new hardware. No retraining.

    Building the Future of Data-Driven Allergy Care

    SkinSight™ AI is the foundation for long-term innovation in allergy testing. Upcoming capabilities will include:

    • Longitudinal comparisons across visits
    • Trend analysis to monitor treatment impact
    • Medication-response insights for more tailored care

    These enhancements will empower practices to move beyond subjective measurement and towards measurable, outcomes-based allergy care.

    Supporting Practices Amid CPT 95004 Pressure

    With reimbursement for CPT 95004 remaining flat, allergy practices must find ways to optimize accuracy and efficiency without increasing labour. SkinSight™ AI helps bridge this gap by:

    • Reducing manual workload
    • Standardizing documentation
    • Supporting outcomes reporting and transparency

    A Platform Built for Modern Allergy, Immunotherapy, and Biologic Care

    ModuleMD, ranked among America's fastest-growing companies on the Inc. 5000 and highly rated on G2, is more than an EHR vendor. They are a specialty-driven platform that runs Allergy/ Immunotherapy, and Biologics workflows directly within the EMR itself.

    SkinSight™ AI is the latest example of ModuleMD's mission: building purpose-built tools that reduce clinical burden, standardize treatment, support precision therapy, and strengthen patient trust all inside one connected allergy platform. To know more on ModuleMD, visit www.modulemd.com

    SkinSight™ Patent Pending*
    (*Asterisk intentionally added to mark proprietary branding.)

    Logo: https://mma.prnewswire.com/media/2637848/Module_MD_Logo.jpg

     

    Cision View original content:https://www.prnewswire.com/news-releases/skinsight-ai-by-modulemd-smarter-skin-analysis-faster-clinical-decisions-302635235.html

    SOURCE ModuleMD Healthcare Solutions Private Limited